PGE2 activates cementoclastogenesis by cementoblasts via EP4

Journal of Dental Research

Volumn 86, Issue 10, 2007, Pages 974-979

  Oka, H ^a   Miyauchi, M ^a   Sakamoto, K ^a   Moriwaki, S ^b   Niida, S ^b   Noguchi, K ^c   Somerman, M J ^d   Takata, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cementoblasts; Periodontal tissue; PGE receptor subtypes; Prostaglandin E2

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL LINE; CEMENTUM; COCULTURE; METABOLISM; MOUSE; OSTEOCLAST; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL LINE, TRANSFORMED; COCULTURE TECHNIQUES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENTAL CEMENTUM; DINOPROSTONE; INTERLEUKIN-6; MICE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 35348826101     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708601011     Document Type: Article

References (28)

1. Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, et al. (1989). Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 4:29-35.
2. Boabaid F, Berry JE, Koh AJ, Somerman MJ, McCauley LK (2004). The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. J Periodontal 75:1247-1254.
3. Carranza FA Jr, Bernard GW (2002). Clinical periodontology. In: The tooth-supporting structures. Newman MG, Takei H, Carranza FA, eds. Carranza's clinical periodontology. 9th ed. Philadelphia: W.B. Saunders, pp. 36-57.
4. Chen Y, Hughes-Fulford M (2000). Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells. Br J Cancer 82:2000-2006.
5. Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ (2005). Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontal 76:813-820.
6. Coleman RA, Smith WL, Narumiya S (1994). International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229.
7. 2alpha on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res 6:157-164.
8. D'Errico JA, Ouyang H, Berry JE, Macneil RL, Strayhorn C, Imperiale MJ, et al. (1999). Immortalized cementoblasts and periodontal ligament cells in culture. Bone 25:39-47.
9. D'Errico JA, Berry JE, Ouyang H, Strayhorn C, Windle JJ, Somerman MJ (2000). Employing a transgenic animal model to obtain cementoblasts in vitro. J Periodontal 71:63-72.
10. Freeman E (1994). Periodontium. In: Oral histology: development, structure and function. Ten Cate AR, editor. St. Louis: Mosby, pp. 276-312.
11. Fujino H, West KA, Regan JW (2002). Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 277:2614-2619.
12. Klein DC, Raisz LG (1970). Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86:1436-1440.
13. Lee SK, Lorenzo JA (2002). Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone 31:252-259.
14. Li X, Pilbeam CC, Pan L, Breyer RM, Raisz LG (2002). Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30:567-573.
15. Liu XH, Kirschenbaum A, Yao S, Levine AC (2005). Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 146:1991-1998.
16. Miyauchi M, Hiraoka M, Oka H, Sato S, Kudo Y, Ogawa I, et al. (2004). Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide. Arch Oral Biol 49:739-746.
17. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, et al. (1993). Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity, Nature 365:166-170.
18. Narumiya S, Sugimoto Y, Ushikubi F (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
19. Negishi M, Sugimoto Y, Ichikawa A (1995). Molecular mechanism of diverse actions of prostanoid receptors. Biochem Biophys Acta 1259:109-119.
20. Raisz LG (1982). Prostaglandins and skeletal metabolism. In: Prostaglandins. Lee JB, editor. New York: Elsevier, pp. 351-372.
21. Raisz LG, Vanderhoek JY, Simmons HA, Kream BE, Nicolaou KC (1979). Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin. Prostaglandins 17:905-914.
22. Sakuma Y, Tanaka K, Suda M, Komatsu Y, Yasoda A, Miura M, et al. (2000). Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. Infect Immun 68:6819-6825.
23. Shinar DM, Rodan GA (1990). Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 126:3153-3158.
24. Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, et al. (2004). Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172:2504-2510.
25. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, et al. (2000). The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141:1554-1559.
26. Takayama K, Sukhova GK, Chin MT, Libby P (2006). A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circ Res 98:499-504.
27. Wani MR, Fuller K, Kim NS, Choi Y, Chambers T (1999). Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140:1927-1935.
28. Yokota K, Kusaka M, Ohshima T, Yamamoto S, Kurihara N, Yoshino T, et al. (1986). Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor. J Biol Chem 261:15410-15415.